☰

Jacobi I. Cunningham, Ph.D. - Publications

Affiliations: 
2010 Boston University, Boston, MA, United States 
Area:
Pharmacology, Behavioral Sciences Psychology
Tree Info Grants Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Tan LA, Gajipara N, Sun L, Bacolod M, Zhou Y, Namchuk M, Cunningham JI. In vivo Characterization of the Opioid Receptor-Binding Profiles of Samidorphan and Naltrexone in Rats: Comparisons at Clinically Relevant Concentrations. Neuropsychiatric Disease and Treatment. 18: 2497-2506. PMID 36345421 DOI: 10.2147/NDT.S373195  0.345
2021 Cunningham JI, Todtenkopf MS, Dean RL, Azar MR, Koob GF, Deaver DR, Eyerman DJ. Samidorphan, an opioid receptor antagonist, attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in male Wistar rats. Pharmacology, Biochemistry, and Behavior. 173157. PMID 33647274 DOI: 10.1016/j.pbb.2021.173157  0.742
2019 Cunningham JI, Eyerman DJ, Todtenkopf MS, Dean RL, Deaver DR, Sanchez C, Namchuk M. Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates. Journal of Psychopharmacology (Oxford, England). 269881119856850. PMID 31294646 DOI: 10.1016/j.euroneuro.2018.11.598  0.695
2019 Cunningham J, Eyerman D, Todtenkopf M, Dean R, Deaver D, Sanchez C, Namchuk M. P.125 Samidorphan, an opioid receptor antagonist, mitigates olanzapine-induced metabolic dysfunction in female rats European Neuropsychopharmacology. 29: S103-S104. DOI: 10.1016/j.euroneuro.2019.09.179  0.748
2019 Cunningham J, Burke N, Todtenkopf M, Finn D, Roche M, Kelly J, Eyerman D, Sanchez C. Samidorphan attenuates the effects of buprenorphine in rat models evaluating abuse potential European Neuropsychopharmacology. 29: S344. DOI: 10.1016/j.euroneuro.2018.11.535  0.35
2019 Smith K, Deaver D, Dean R, Cunningham J, Sanchez C, Eyerman D. Mu dependent effects of buprenorphine in combination with samidorphan on immobility behavior in Wistar Kyoto rats European Neuropsychopharmacology. 29: S63-S64. DOI: 10.1016/j.euroneuro.2018.11.1041  0.752
2019 Cunningham J, Eyerman DJ, Todtenkopf M, Dean RL, Deaver DR, Sanchez C, Namchuk MN. F160. Samidorphan, an Opioid Receptor Antagonist, Mitigates Olanzapine-Induced Metabolic Dysfunction in Female Rats Biological Psychiatry. 85: S275. DOI: 10.1016/j.biopsych.2019.03.697  0.736
2018 Smith KL, Cunningham JI, Eyerman DJ, Dean RL, Deaver DR, Sanchez C. Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat. Neuropharmacology. PMID 30448421 DOI: 10.1016/j.neuropharm.2018.11.015  0.755
2015 Cunningham J, Smith K, Dean R, Deaver D, Eyerman D. P.2.a.016 The effects of buprenorphine in combination with samidorphan on neurochemical and behavioral measures in Wistar Kyoto rats European Neuropsychopharmacology. 25: S384. DOI: 10.1016/S0924-977X(15)30500-9  0.743
2014 Cunningham J, Dean R, Todtenkopf M, Azar M, Koob G, Deaver D, Eyerman D. P.3.a.009 Samidorphan attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in rats European Neuropsychopharmacology. 24: S489. DOI: 10.1016/S0924-977X(14)70782-5  0.724
2014 Todtenkopf M, Dean R, Eyerman D, Cunningham J, Deaver D. P.2.a.010 Buprenorphine in combination with samidorphan (ALKS 33) results in antidepressive-like effects in two distinct rat models European Neuropsychopharmacology. 24: S366-S367. DOI: 10.1016/S0924-977X(14)70585-1  0.738
2013 Anneken JH, Cunningham JI, Collins SA, Yamamoto BK, Gudelsky GA. MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 58-65. PMID 23179355 DOI: 10.1007/S11481-012-9420-X  0.617
2009 Cunningham JI, Raudensky J, Tonkiss J, Yamamoto BK. MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning. Behavioral Neuroscience. 123: 1076-84. PMID 19824774 DOI: 10.1037/A0016716  0.655
2009 Bhide NS, Lipton JW, Cunningham JI, Yamamoto BK, Gudelsky GA. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain. Brain Research. 1286: 32-41. PMID 19555677 DOI: 10.1016/J.Brainres.2009.06.042  0.628
Show low-probability matches.